Artal Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Artal Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$977K	–	150
2021 Q4	$977K	Hold	100,000	–	–	0.03%	140
2021 Q3	$3.4M	Sell	100,000 -100,000	-50%	-$3.19M	0.08%	124
2021 Q2	$7.32M	Hold	200,000	–	–	0.15%	106
2021 Q1	$8.97M	Sell	200,000 -300,000	-60%	-$14M	0.16%	102
2020 Q4	$28.5M	Sell	500,000 -100,000	-17%	-$5.93M	0.61%	43
2020 Q3	$30.8M	Sell	600,000 -50,000	-8%	-$2.45M	0.75%	30
2020 Q2	$38.8M	Sell	650,000 -150,000	-19%	-$8.02M	1.09%	23
2020 Q1	$32.9M	Buy	800,000 +550,000	+220%	+$30.5M	1.39%	22
2019 Q4	$15.6M	Sell	250,000 -250,000	-50%	-$11.9M	0.6%	29
2019 Q3	$17M	Buy	+500,000	New	+$14.8M	0.68%	29

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Artal Group's DCPH Position: Q1 2022 in Review

Artal Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 100,000 shares — an estimated $977K sold.

Artal Group first reported a position in DCPH in Q3 2019 and held it in 10 quarters. The position peaked at $38.8M in Q2 2020. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Artal Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Artal Group sold 100,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $977K.
Artal Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
Artal Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $38.8M in Q2 2020.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Artal Group's 13F filing for Q1 2022, filed 12 May 2022.